| ISIN | LU1630052980 |
|---|---|
| Valor Number | 37084658 |
| Bloomberg Global ID | |
| Fund Name | PROTEA - Lapis Global Top 50 Dividend Yield Fund C CHF |
| Fund Provider |
Valori Asset Management SA
Viale Alessandro Volta 16 6830 Chiasso Switzerland |
| Fund Provider | Valori Asset Management SA |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the Company with respect to the fund is to achieve long term capital growth through the investment of its assets in a portfolio of shares and other equity securities or equity rights of – in principle – 50 corporations having their registered office or the major part of their business activities in recognised countries. In principle, the corporations must have a market capitalisation of over USD 25 billion. |
| Peculiarities | In Liquidation |
| Current Price * | 112.26 CHF | 08.01.2026 |
|---|---|---|
| Previous Price * | 110.97 CHF | 07.01.2026 |
| 52 Week High * | 112.26 CHF | 08.01.2026 |
| 52 Week Low * | 108.96 CHF | 24.11.2025 |
| NAV * | 112.26 CHF | 08.01.2026 |
| Issue Price * | 112.26 CHF | 08.01.2026 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 146,808,598 | |
| Unit/Share Assets *** | 324,458 | |
| Trading Information SIX | ||
| YTD Performance | +1.75% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| 1 month | +1.10% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +2.49% |
21.11.2025 - 08.01.2026
21.11.2025 08.01.2026 |
| 6 months | - | - |
| 1 year | - | - |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Merck & Co Inc | 2.43% | |
|---|---|---|
| GSK PLC | 2.29% | |
| Roche Holding AG | 2.24% | |
| National Bank of Canada | 2.23% | |
| Medtronic PLC | 2.20% | |
| AbbVie Inc | 2.20% | |
| Royal Bank of Canada | 2.17% | |
| Novo Nordisk AS Class B | 2.16% | |
| Enbridge Inc | 2.10% | |
| TotalEnergies SE | 2.08% | |
| Last data update | 30.11.2025 | |
| TER *** | 0.756% |
|---|---|
| TER date *** | 30.11.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.45% |
| Ongoing Charges *** | 0.76% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |